Adding Celecoxib with or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results from an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial Malcolm D. Mason , Noel W. Clarke , Nicholas D. James , David P. Dearnaley , Melissa R. Spears , Alastair W. S. Ritchie , Gerhardt Attard , William Cross , Rob J. Jones , Christopher C. Parker , J. Martin Russell , George N. Thalmann , Francesca Schiavone , Estelle Cassoly , David Matheson , Robin Millman , Cyrill A. Rentsch , Jim Barber , Clare Gilson , Azman Ibrahim , John Logue , Anna Lydon , Ashok D. Nikapota , Joe M. O'Sullivan , Emilio Porfiri , Andrew Protheroe , Narayanan Nair Srihari , David Tsang , John Wagstaff , Jan Wallace , Catherine Walmsley , Mahesh K. B. Parmar , Matthew R. Sydes JOURNAL OF CLINICAL ONCOLOGY（2017）
Key words
Metastatic Prostate Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
